Brevan Howard Capital Management LP Vera Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 7,614 shares of VERA stock, worth $352,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,614Holding current value
$352,223% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$199 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$182 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$154 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$137 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$129 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.25B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...